BIS-F Stock Overview
Manufactures and distributes pharmaceutical supplies, medical devices, and equipment in Thailand. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Bioscience Animal Health Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿6.00 |
| 52 Week High | ฿0 |
| 52 Week Low | ฿0 |
| Beta | 0.79 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIS-F | TH Healthcare | TH Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | 0.3% |
| 1Y | 0% | -9.3% | 3.2% |
Return vs Industry: BIS-F exceeded the TH Healthcare industry which returned -9.3% over the past year.
Return vs Market: BIS-F underperformed the TH Market which returned 3.2% over the past year.
Price Volatility
| BIS-F volatility | |
|---|---|
| BIS-F Average Weekly Movement | 0% |
| Healthcare Industry Average Movement | 4.3% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TH Market | 10.1% |
| 10% least volatile stocks in TH Market | 2.4% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine BIS-F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Dhanawat Khongjaroensombat | www.bis-group.com/en/our-subsidiaries/bioscience-animal-health |
Bioscience Animal Health Public Company Limited manufactures and distributes pharmaceutical supplies, medical devices, and equipment in Thailand. The company offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services.
Bioscience Animal Health Public Company Limited Fundamentals Summary
| BIS-F fundamental statistics | |
|---|---|
| Market cap | ฿1.08b |
| Earnings (TTM) | ฿62.67m |
| Revenue (TTM) | ฿2.39b |
17.2x
P/E Ratio0.5x
P/S RatioIs BIS-F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIS-F income statement (TTM) | |
|---|---|
| Revenue | ฿2.39b |
| Cost of Revenue | ฿2.03b |
| Gross Profit | ฿358.56m |
| Other Expenses | ฿295.90m |
| Earnings | ฿62.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.20 |
| Gross Margin | 14.98% |
| Net Profit Margin | 2.62% |
| Debt/Equity Ratio | 0.8% |
How did BIS-F perform over the long term?
See historical performance and comparison